Hana Biosciences' Marqibo Receives Orphan Designation From European - MSN MoneyCentral
SOUTH SAN FRANCISCO, Calif., July 14, 2008 (PRIME NEWSWIRE) — Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the European Commission has granted orphan medical

Hana Biosciences's Marqibo gets orphan drug designation from European - Forbes
BOSTON (Thomson Financial) - Hana Biosciences Inc. Monday said the European Commission has granted orphan medical product designation to Marqibo for the treatment of adult acute lymphoblastic leukemia. The South San Francisco, Calif.-based

Van Buren school chief hospitalized with leukemia - Ann Arbor News Blog
Van Buren schools Superintendent Pete Lazaroff has been hospitalized with acute lymphatic leukemia, the district said in a press release Monday. According to the district, Lazaroff was diagnosed after he went to St. Joseph Mercy Hospital on Friday

Cephalon: 92% of patients responded to Treanda plus rituximab in Phase - CNBC
NEW YORK (Thomson Financial) - Cephalon Inc. Tuesday said 92% of non-Hodgkin's lymphoma patients in a Phase 2 study responded to treatment with the company's drug Treanda and rituximab, a chimeric monoclonal antibody used to treat lymphoma and

West suburban veterinarian used holistic healing - Chicago Tribune
In addition to traditional methods, Dr. Patricia Martin, a veterinarian in the west suburbs, used acupuncture treatments, Chinese herbs and a calming touch to treat the animals in her care. "She was kind and gentle and able to take the time to calm

Tumor-inhibiting protein could be effective in treating leukemia - Genetic Engineering News
Angiocidin, a tumor-inhibiting novel protein discovered by Temple University researchers, may also have a role as a new therapeutic application in treating leukemia, according to a study by the researchers. The study, "The Novel Angiogenic Inhibitor